Analytical Data
-
Gene name
MALD3
- Application
-
Alternative Names
MALD3；MRVLDC3；MARVEL domain-containing Protein 3
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96A59
-
Expression Region
1-401aa
-
AA Sequence
MEDPSGAREPRARPRERDPGRRPHPDQGRTHDRPRDRPGDPRRKRSSDGNRRRDGDRDPERDQERDGNRDRNRDRERERERERDPDRGPRRDTHRDAGPRAGEHGVWEKPRQSRTRDGARGLTWDAAAPPGPAPWEAPEPPQPQRKGDPGRRRPESEPPSERYLPSTPRPGREEVEYYQSEAEGLLECHKCKYLCTGRACCQMLEVLLNLLILACSSVSYSSTGGYTGITSLGGIYYYQFGGAYSGFDGADGEKAQQLDVQFYQLKLPMVTVAMACSGALTALCCLFVAMGVLRVPWHCPLLLVTEGLLDMLIAGGYIPALYFYFHYLSAAYGSPVCKERQALYQSKGYSGFGCSFHGADIGAGIFAALGIVVFALGAVLAIKGYRKVRKLKEKPAEMFEF
-
Molecular Weight
44.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MALD3, a member of the MALD family of proteins, has garnered attention in the field of molecular biology due to its potential applications in therapeutic and biotechnological contexts. As a recombinant protein, MALD3 is produced through genetic engineering techniques, which allow for the amplification and expression of the gene encoding this protein in host organisms, such as bacteria or yeast. Research into MALD3 focuses on its structural characteristics, functional properties, and interactions with other biomolecules. The protein is thought to play a role in various biological processes, including cell signaling and immune responses. Notably, MALD3 has also been implicated in enhancing the efficacy of vaccine development and delivery systems, making it a promising candidate for improving immunogenicity. As scientists continue to unravel the mechanisms underlying MALD3's functionality, the protein's potential as a tool for targeted drug delivery and therapeutic interventions becomes increasingly relevant. Furthermore, investigations into optimizing production methods of MALD3 aim to enhance yield and stability, crucial factors for its application in research and medicine. The study of MALD3 not only deepens our understanding of protein biology but also paves the way for innovative solutions in combating diseases and advancing biotechnological innovations.
